Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
about
Decontamination of environmental surfaces in hospitals to reduce hospital acquired infectionsQuarantine, isolation, and cohorting: from cholera to KlebsiellaTreatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control.Duration of colonization with vancomycin-resistant Enterococcus.Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms.Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic reviewClinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.Characterization of glycopeptide-resistant enterococci from a Swiss hospital.Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditisComparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.Vancomycin-resistant Enterococcus faecium colonization in childrenComparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients.Proficiency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus spp. The Spanish VRE Study Group.Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak.Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden.Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonalityPrevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of FranceRelationships between enterococcal virulence and antimicrobial resistance.Vancomycin-resistant enterococci.Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans?Transfer of the pheromone-inducible plasmid pCF10 among Enterococcus faecalis microorganisms colonizing the intestine of mini-pigs.Prosthetic biologic valve endocarditis caused by a vancomycin-resistant (vanA) Enterococcus faecalis: case report.Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.Development and spread of bacterial resistance to antimicrobial agents: an overview.Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.Antibiotic resistance: prospects for the new millennium.Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococciActivities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci
P2860
Q24236713-AC6580CD-4A46-4751-84F3-1907BA271294Q26997796-6A9AAC13-9392-424F-A460-F91BA5300C1EQ28367434-81464D69-50F1-4A97-B2A3-F54D0F2B5985Q30307268-DE2E2E54-C309-4D8B-BB5B-62AA871EEB28Q30309321-6601C593-1517-463B-877A-BE05D302CD88Q30359186-AA6013D1-4FCA-46F9-9E28-2DADB0771C70Q33281709-BDD3DE90-AEB5-4BBB-B0AF-D87260B95001Q33565503-C5E28512-98ED-4363-A41A-6CC6036E60EAQ33599435-252BEA27-CB12-45BD-B73C-2C0FB5152B99Q33656986-FAD0CCEF-3B48-44E7-9C58-15441C220A3AQ33671926-7571BD6E-DFCC-41D7-AB68-B503A7CCFE22Q33688030-A8A7F08B-9EE6-4539-9B3C-EE9DEA0DEB9CQ33693084-39A80B2D-FDCB-4FC7-898E-4C8381541808Q33751682-7CA83DA0-5E70-4EA9-BA41-19BD976D2DF0Q33758823-471FFD05-7C16-41A4-98A5-51213E868F73Q33958749-C13D943F-FF54-46A2-9864-F7A2CC7EE777Q33960216-F8D725BE-589A-4FBA-9509-E3819D4F44D9Q33961363-52EB2F6A-7F4A-4AEE-A430-033AEB1DFA69Q33963077-53638377-9CBC-41C1-A9AE-C9F5A02FBFECQ33963496-6946BC01-EFD5-48AC-BFF2-E2A082C0BA50Q33964133-3D0DA013-7DDF-4B57-A6ED-47B8CC38230CQ33964155-EE11FB85-79BD-440F-868E-B0BD02858750Q33965352-2A882C62-CCD6-4411-8557-19B789CF3DC8Q33975543-B70EF775-C1C4-4C0D-A561-373CA38C3E88Q33975592-164333F9-D742-427E-8BA1-634D3FE145E5Q33976380-E10067E6-D1E2-436D-82EC-757E5535D708Q33976567-AB57BE39-E614-4089-9C3F-4E8C6AA140D8Q33977633-F18D3FA0-3593-4DC3-BAB1-178563F270C4Q34096804-FDD75FD2-B62A-4A43-9166-179999CA8D33Q34112449-9CC54B17-7A2F-4D7F-AF86-5812325C408FQ34189603-C254F2C0-31B4-4316-95F4-D2B8131F3E18Q34347837-E97EA8DC-48FA-4C44-BC8D-0619FC56D529Q34471269-4A467AB8-6F8E-4E16-BF2D-3791B52B20A7Q34503819-E1C78713-939E-4AE9-9992-B0B5EFB9C258Q34645156-36020FE4-036E-423B-BBD6-B6A7576878D8Q35120483-8F4DB60A-5084-4C92-88AB-B5DAA9000E59Q35123641-5E7736DE-6294-4C47-B2DB-D0D36F1C87E3Q35125178-5C2D3BD5-21E1-4626-87AB-6B06E32B332BQ35126947-C5E70091-B029-42F8-BBC8-4D76D4D3D130Q35127151-52A4DCBF-4F07-4D68-AB0C-0980E48F5679
P2860
Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Nosocomial outbreak due to Ent ...... n, penicillin, and gentamicin.
@en
type
label
Nosocomial outbreak due to Ent ...... n, penicillin, and gentamicin.
@en
prefLabel
Nosocomial outbreak due to Ent ...... n, penicillin, and gentamicin.
@en
P2093
P356
P1476
Nosocomial outbreak due to Ent ...... n, penicillin, and gentamicin.
@en
P2093
Handwerger S
Marchione S
P304
P356
10.1093/CLIND/16.6.750
P407
P577
1993-06-01T00:00:00Z